ERD

Surgery for advanced intrahepatic cholangiocarcinoma warrants further investigation

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Midterm recruitment report of CCA patients and patients predisposed to develop CCA

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Immunotherapies in clinical development for biliary tract cancer

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Current and Future Systemic Therapies in Biliary Tract Cancer

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Report of the kick-off meeting

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands.

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience.

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Implicit bias in region-dependent publication potential can partly be counteracted by Academic collaboration

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs ...

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Current impact of viral hepatitis on liver cancer development: The challenge remains

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Midterm recruitment report of HCC patients and patients at risk of developing HCC

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

First dissemination report

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Hepatobiliary cancers in South America: disparity strikes

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Chol...

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Diagnostic and prognostic biomarkers in cholangiocarcinoma

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Hepatocellular carcinoma, a unique tumor with a lack of biomarkers

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

NAFLD‐Related Hepatocellular Carcinoma and the Four Horsemen of the Apocalypse

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Circulating biomarkers for early detection of hepatocellular carcinoma

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Hepatocellular Carcinoma: Unraveling the Role of Occult Hepatitis B Virus Infection

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

PIGR-enriched circulating vesicles contributes to hepatocellular carcinoma aggressiveness

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical impli...

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Hepatocellular carcinoma

Project: ESCALON

Updated at: 30-10-2023

Show more information

Project acronym ESCALON

Resources

Selected filters:

Surgery for advanced intrahepatic cholangiocarcinoma warrants further investigation

Midterm recruitment report of CCA patients and patients predisposed to develop CCA

Immunotherapies in clinical development for biliary tract cancer

Current and Future Systemic Therapies in Biliary Tract Cancer

Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy

Report of the kick-off meeting

Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands.

Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience.

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Implicit bias in region-dependent publication potential can partly be counteracted by Academic collaboration

Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor

Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs ...

Current impact of viral hepatitis on liver cancer development: The challenge remains

Midterm recruitment report of HCC patients and patients at risk of developing HCC

First dissemination report

Hepatobiliary cancers in South America: disparity strikes

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Chol...

Diagnostic and prognostic biomarkers in cholangiocarcinoma

Hepatocellular carcinoma, a unique tumor with a lack of biomarkers

Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer

NAFLD‐Related Hepatocellular Carcinoma and the Four Horsemen of the Apocalypse

Circulating biomarkers for early detection of hepatocellular carcinoma

Hepatocellular Carcinoma: Unraveling the Role of Occult Hepatitis B Virus Infection

PIGR-enriched circulating vesicles contributes to hepatocellular carcinoma aggressiveness

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.

Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer

Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical impli...

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?

Hepatocellular carcinoma